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Abstract
The aim of this study was to investigate the effectiveness of guidance assistance during transbronchial biopsy (TBB) to 
achieve an appropriate pathway to small and peripheral pulmonary lesions (PPLs) using a combination of fluoroscopy and 
specialized ray-summation (Ray-sumTBB) images, which were processed from preprocedural lung computed tomography 
(CT) images. To improve the visibility of the correct pathway to the PPLs, three-dimensional spatial resolution enhance-
ment and CT number conversion processes were applied to the original CT images. The Ray-sumTBB images reconstructed 
from the processed CT images were used as additional guides. We compared the rates of successful tumor localization and 
biopsy (arrival rate) between the trial (with Ray-sumTBB) and control (without Ray-sumTBB) groups. The fluoroscopy and 
examination times were also compared. The arrival rate of the trial group (73.1%) was significantly better than that of the 
control group (42.3%) (p = 0.048). The fluoroscopy and examination times did not differ significantly between the trial 
and control groups. No complications were identified in the trial group. Our results suggest that Ray-sumTBB improves the 
diagnostic accuracy of TBB.
Keywords Transbronchial biopsy · Ray-summation · Frequency processing · Peripheral pulmonary lesion · Ground-glass 
opacity · Endobronchial ultrasound
1 Introduction
Flexible bronchoscopy is generally accepted as the gold 
standard method for assessing lung nodules. The minimally 
invasive transbronchial biopsy (TBB) assists in diagnosing 
lung diseases. Previous studies have reported that the 
diagnostic accuracy of TBB for peripheral pulmonary 
lesions (PPLs) exceeds 80.0% [1, 2]. However, according 
to the American College of Chest Physicians Lung Can-
cer Guidelines (2nd edition) [2], the diagnostic yield for 
lesions < 20 mm in diameter is as low as 34.0% [3]. How-
ever, PPLs that are > 8 mm are more likely to be malignant 
[4]. Thus, more accurate methods for diagnosing PPLs that 
are < 20 mm in diameter are required.
The diagnostic yield of TBB for PPLs depends on several 
factors, including the selected sampling method, lesion size, 
lesion location, and physician’s skill [5-9]. Although com-
puted tomography (CT)-guided TBB is an effective method 
for diagnosing PPLs [10, 11], it requires exposure to excess 
doses of radiation from repeated CT scanning [10]. To fur-
ther improve the diagnostic yield, CT-guided TBB with 
virtual bronchoscopy navigation (VBN) is often performed 
[12-15]. Other novel hardware- and software-guided TBB 
techniques for improving the diagnostic yield of TBB have 
also been introduced and applied in clinical practice over the 
past decade [16-20]. Specifically, the bronchoscopic trans-
parenchymal nodule access [16, 17], a method of pathway 
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planning using fluoroscopic guidance could effectively be 
used in performing procedures.
Fluoroscopic guidance is widely used during TBB; how-
ever, it is associated with some essential disadvantages. 
First, the guidance images are two-dimensional (2D) projec-
tions, which make it difficult to understand the three-dimen-
sional (3D) anatomical relationships among the projected 
objects. Second, the contrast resolution of fluoroscopic guid-
ance images is often insufficient, and sometimes suboptimal, 
specifically when low-radiation doses are used. Certainly, 
several PPLs that feature ground-glass opacities (GGOs) 
and low attenuation are not visible on fluoroscopic images 
[21, 22]. Yoshikawa et al. [23] even reported that adding 
fluoroscopy to TBB for PPLs that are < 20 mm has no diag-
nostic advantage. Although these disadvantages are known, 
fluoroscopic guidance remains popular, because most hos-
pitals have fluoroscopic examination room(s) and it is easy 
to perform. The value of fluoroscopy in TBB remains to be 
clarified.
In this study, we propose a novel image guidance method 
for TBB of PPLs using ray-summation (Ray-sumTBB) 
images, which are reconstructed from routine preprocedural 
CT images. This guidance technique is intended for use 
during TBB examinations with a thin bronchoscope, radial 
endobronchial ultrasound (EBUS) using a guide sheath 
[24], and fluoroscopic guidance (the routine TBB examina-
tion method in our hospital). The purpose of this study was 
to compare the rates of successful tumor localization and 
biopsy (arrival rate) between TBB in combination with Ray-
sumTBB image guidance and TBB alone.
2  Materials and methods
2.1  Ray‑summation images for transbronchial 
biopsy (TBB) assistance
The ray-summation technique used to generate Ray-sumTBB 
is an application consisting of 3D-CT images, typically 
implemented in commercially available 3D-CT worksta-
tions. The technique produces projection images, which 
mimic general radiographs, by projecting (adding) voxel 
data in a CT volume data, along each projection path (ray). 
The volume data are typically constructed with consecutive 
thin-slice CT images. In general, the ray-summation images 
can be manipulated using a computer mouse, enabling the 
observer to freely change the projection angle. Thus, the 
observer can view the mimicked radiograph from any angle 
as if the observer changes the patient’s posture during fluor-
oscopy. Our proposed method combines this ray-summation 
image display with fluoroscopy to improve the guidance dur-
ing TBB of PPLs. We initially tested normal ray-summation 
images for TBB assistance. However, the bronchoscopists in 
our TBB team declined the use of the normal ray-summation 
images, because the images provided only a slight contrast 
enhancement and the image resolution was insufficient.
We applied several image processing techniques to the 
CT image dataset to improve the visibility of the endoscopic 
pathway (tracheobronchial tree to the lesion) and tumor 
within the Ray-sumTBB images. The outline flow of the pro-
cesses is presented in Fig. 1. Ray-summation images typi-
cally have insufficient spatial resolution, because the matrix 
size of the original CT images is limited to 512 × 512. This is 
significantly inferior to those of digital fluoroscopic images 
having at least 1024 × 1024 matrix size; hence, we first 
applied 3D spatial resolution enhancement [25, 26] to the 
CT image set using in-house software developed by MAT-
LAB version R2016a (MathWorks Inc., Novi, MI, USA). 
First, the CT image data (i.e., the 3D volume data) were 
transformed to 3D Fourier domain data using a 3D Fourier 
transformation. Following this, the 2D frequency processing 
factor for each slice (x–y) plane, as shown in Fig. 2a, was 
multiplied to each plane. Subsequently, a one-dimensional 
frequency processing factor for the longitudinal (z) direction, 
as shown in Fig. 2b, was multiplied to each z-directional 
profile at all x, y positions. Finally, the processed (enhanced) 
Original CT image dataset
(3D data)
3D spatial resolution enhancement
Enhanced CT image dataset






Processed CT image dataset
Sending to 3D-workstation
Fig. 1  Outline process flow for enhancing the computed tomography 
image dataset used for reconstructing ray-summation images. The 
reconstructed ray-summation images were used as additional guid-
ance images in transbronchial biopsy examination
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3D volume data were obtained using an inverse 3D Fourier 
transformation.
Following the above-mentioned spatial resolution 
enhancement, the data were once loaded to the 3D-CT work-
station (Zio Station2; Ziosoft, Tokyo, Japan) to extract the 
airway and tumor. The pathway was identified using several 
operations in the 3D-CT workstation, with a threshold of 
-940 Hounsfield units (HU). The tumor was identified using 
a 3D region of interest tool with appropriate thresholding 
depending on the CT number of tumor. Onodera et al. [27] 
previously demonstrated the advantages of using the pul-
monary artery bundled with the bronchus to predict a more 
peripheral route. Therefore, we identified the pulmonary 
artery, using a threshold of around -60 HU, when periph-
eral bronchi were not visible on CT images. The identified 
regions were exported as 2D binary images with the same 
slice (image) number and matrix size of the original CT 
images. Subsequently, we applied CT number conversion 
processing to the CT image set using in-house software with 
MATLAB, referring to the 2D binary images. The CT num-
ber of the pathway was converted to + 6000 HU to simu-
late the bronchography using a contrast medium. The CT 
numbers of the tumor and pulmonary artery were converted 
to + 4000 HU and + 5000 HU, respectively. These HU con-
version processes enable to observe three objects (pathway, 
tumor, and pulmonary artery) with different contrast. The 
processed CT image set was again loaded into the 3D-CT 
workstation, and the Ray-sumTBB image was visualized on 
the 3D-CT workstation display. Figure 3 shows the examples 
of a normal ray-sum image, Ray-sumTBB image, and digi-
tal radiograph for the same patient. The Ray-sumTBB image 
had markedly improved spatial resolution and resembled 
the digital radiographic depiction. The images in this study 
were obtained after the institutional ethics review board 
approved this study. Figure 4 shows Ray-sumTBB images 
with enhanced airways, enhanced pulmonary arteries, and 
enhanced airways and pulmonary arteries for comparison. 
Figure 5 shows the display layout during the TBB examina-
tion with Ray-sumTBB. The fluoroscopic and Ray-sumTBB 
images are displayed side by side throughout the procedure. 
During TBB, the assistant radiologist manipulated the com-
puter mouse of the 3D-CT workstation to select the optimal 
viewing angles and magnifications, according to the fluoro-
scopic images being displayed during the TBB examination. 
The automatic image matching and registration processes 
were not included in our technique.
The motivation for our approach is attributed to the 
clinical demand of the bronchoscopists in our TBB team to 
observe the fluoroscopy image more clearly and to identify 
thinner bronchia, tumors, and, if possible, arteries around the 
bronchus. It has been well known that the fluoroscopy-like 
images are generated by the ray-summation process using a 
3D-CT image dataset; however, the bronchus is not clearly 
visualized by normal ray-summation image as is; moreover, 
Fig. 2  Spatial frequency processing factors were calculated from the 
ratio of modulation transfer factor obtained from the flat panel detec-
tor of fluoroscopy system and computed tomography. Spatial fre-
quency processing factors for the a x–y plane and b z direction that 
were applied to the original computed tomography image dataset for 
improving the spatial resolution of ray-summation images to a level 
that was similar to that of fluoroscopic images
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Fig. 3  Examples of a normal ray-summation b ray-summation for 
transbronchial biopsy (Ray-sumTBB), and c digital radiography 
images acquired from a single patient. The spatial resolution was 
markedly improved in the Ray-sumTBB image, approaching that of the 
digital radiography image
Fig. 4  Comparison of ray-summation images for transbronchial biopsy with a enhanced airways b enhanced pulmonary arteries, and c enhanced 
airways and pulmonary arteries
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identification of small tumors and arteries around the bron-
chus is often difficult. Thus, the spatial resolution enhance-
ment and CT number conversions, which were specialized 
for TBB, were required items.
2.2  Patient population
This study was approved by our institutional ethics review 
board, and all patients provided informed consent for inclu-
sion in the study. We enrolled 26 consecutive patients 
between July and December 2016 in the TBB examination 
with the Ray-sumTBB (trial) group. For the control group, we 
retrospectively reviewed the cases of 26 patients in whom 
TBB was performed without Ray-sumTBB between Janu-
ary and June 2016. Eligible patients had PPLs with diam-
eters < 20 mm positioned in the peripheral bronchus. The 
PPLs were not directly visible through the endoscope. The 
baseline clinical characteristics of the population are pre-
sented in Table 1. No significant between-group differences 
in age, sex, or lesion size were identified. One patient in the 
control group and four patients in the trial group exhibited 
GGOs. Seven patients in the control group and 15 patients 
in the trial group had tumors that were not visible on fluoro-
scopic images.
2.3  Computed tomography scanning
Preprocedural CT examinations were performed for all 
patients within 1 week prior to each TBB examination using 
a 64-slice multi-detector row CT scanner (Aquilion CXL; 
Canon Medical, Otawara, Japan). The scanning param-
eters were as follows: 120 kVp; detector configuration, 
64 × 0.5 mm; pitch factor, 0.54; and 0.5 s/rotation. Auto-
matic tube current modulation (Real EC; Canon medical) 
was used with a prescribed noise index of 10 to adjust the 
radiation doses. Reconstruction parameters included a slice 
thickness of 0.5 mm, increments of 0.25 mm, and a recon-
struction kernel of FC81 for the lung. The resultant volume 
CT dose index values ranged from 14.1 to 23.6 mGy. The 
above-mentioned scan was routine-based; thus, we did not 
perform any additional scans for obtaining Ray-sumTBB. 
The size of each PPL was measured along the minimal and 
maximal diameters by the three radiologists with 35, 28, and 
13 years of experience and recorded in the patient’s medical 
record.
2.4  TBB examination
Each patient was premedicated with 15 mg of pentazo-
cine hydrochloride and 0.5 mg of atropine sulfate. Local 
anesthesia of the upper respiratory tract was achieved with 
4% lidocaine, in line with the standard of care for TBB. 
Examinations were performed using an ultrathin broncho-
scope with an external diameter of 2.8 mm (BF-P260F; 
Olympus, Tokyo, Japan) in combination with a miniature 
ultrasound probe (20 MHz, mechanical radial type, UM-
S20-20R; Olympus) and a guide sheath kit (SG-201C; 
Olympus). The probe was connected to an EBUS system 
Fig. 5  Display layout during the 
transbronchial biopsy examina-
tion with ray-summation (Ray-
sumTBB) assistance
Table 1  Baseline characteristics of patients in the control (without 
Ray-sumTBB) and trial (with Ray-sumTBB) groups
* Statistically significant difference p < 0.05
Characteristic Control group Trial group p value
Period 2016.1–2016.6 2016.7–2016.12
Age (years) 68.6 ± 10.6 66.3 ± 14.2 0.072
Males:females 15:11 19:7 0.382
Tumor size (mm) 16.3 ± 2.4 15.3 ± 2.9 0.174
Existing GGO 1 4 0.350
Not visible in fluoros-
copy
7 15 0.048*
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(EVIS LUCERA; EU-ME2; Olympus). We used 1.0-mm-
diameter biopsy forceps (FD-44-D-1; Olympus). If needed, 
a double-hinged curette (CC-6DR-1; Olympus) was used to 
direct the guide sheath. We used the CUREVISTA fluoros-
copy system (Hitachi, Ltd., Tokyo, Japan). All examinations 
were performed by two pulmonologists with 17 and 10 years 
of experience, respectively. The other staff consisted of one 
nurse and one radiological technologist. Complications such 
as hemoptysis and pneumothorax were recorded. Fluoros-
copy times and examination times were measured to evaluate 
the outcomes associated with the two guidance techniques. 
Fluoroscopy times were obtained from the fluoroscopy sys-
tem, and examination times were obtained from the Solemio 
endoscopy system (Olympus) at the end of the procedure.
2.5  Evaluation and analysis
We evaluated the arrival rate, rather than the diagnostic 
yield, which is typically assessed in TBB studies, because 
this study aimed to evaluate the effectiveness of fluoroscopy 
combined with Ray-sumTBB for correctly guiding the forceps 
to the tumor; as such, the diagnostic yields of this study 
mean the same as the arrival rates. All patients suspected to 
have cancer were not pathologically confirmed.
We used Student’s t tests to compare the average fluor-
oscopy and examination times as continuous variables and 
Fisher’s exact test to compare the arrival rates as categorical 
variables. The statistical software Statistical Package for the 
Social Sciences (SPSS), version 24 for Windows (SPSS Inc., 
Chicago, IL, USA), was used for all statistical analyses. Dif-
ferences were considered statistically significant at p < 0.05.
3  Results
Table 2 shows the resultant arrival rates, fluoroscopy times, 
and examination times for each of the two groups (trial and 
control). The arrival rate was significantly higher in the trial 
group than that of the control group (p = 0.048). Among 
patients whose tumors were not visible on fluoroscopic 
images, the trial group showed a slightly, but not signifi-
cantly, higher arrival rate than did the control group. No 
significant between-group differences in the fluoroscopy 
times or examination times were identified. Detailed results 
are shown in Table 3 (control group) and 4 (trial group).
4  Discussion
During fluoroscopic guidance for TBB, spatial information 
is only provided in two dimensions, and there tends to be 
insufficient contrast resolution, specifically in the peripheral 
bronchi and for GGOs. These weaknesses frequently lead 
to uncertain and inadequate guidance. To improve the guid-
ance during TBB, we introduced a method that employed 
Ray-sumTBB assistance. Using the Ray-sumTBB images, the 
bronchus, pathway, and tumor (and pulmonary artery in 
two patients) were clearly visible, enabling easy angulation 
according to the fluoroscopic images. No complaints related 
to the procedure were recorded by either pulmonologist. In 
one patient in whom pulmonary artery enhancement was 
observed (No. 45 in Table 4), the forceps reached the tumor 
because of guidance assistance, in combination with the pul-
monary artery display. Even when the bronchoscope moved 
unexpectedly due to coughing or body movements, the bron-
choscopist was able to identify a deviation by comparing 
between Ray-sumTBB of pathway and fluoroscopic image of 
the catheter head position. This enabled a smooth recovery 
following the disturbance and continued advancement of the 
forceps. Thus, adding Ray-sumTBB did not complicate the 
TBB procedure, and no significant fluoroscopy or examina-
tion time differences (extensions) were observed between 
TBB with and without Ray-sumTBB, although we expected 
that the Ray-sumTBB assistance shortens the fluoroscopy 
and examination times. As a result, no increase in radiation 
exposure to the patients and pulmonologists were caused by 
adding the assistance of Ray-sumTBB.
Here, TBB with Ray-sumTBB was associated with a 
significantly better arrival rate, although the trial group 
included more patients in whom the PPLs were not visible 
on fluoroscopic images compared to the control group. Oki 
et al. [28] conducted a multicenter study that compared the 
diagnostic yields between patients who underwent EBUS, 
fluoroscopy, and VBN guidance with a 3.0-mm ultrathin 
bronchoscope or a 4.0-mm thin bronchoscope with a 
guide sheath. In that study, the diagnostic yields were 74% 
(median lesion size, 19.0) in the 3.0-mm ultrathin bron-
choscope group and 59% (median lesion size, 19.4 mm) in 
the 4.0-mm thin bronchoscope with a guide sheath group 
[28]. Another study comparing patients who did and did 
not receive VBN assistance found diagnostic yields of 
67.1% (median lesion size, 17.5 mm) in the VBN-assisted 
group and 59.9% (median lesion size, 17.0 mm) in the 
Table 2  Arrival rate, fluoroscopy time, and examination time in the 
control and trial groups
ns not significant
* Statistically significant difference p < 0.05
Control group Trial group p value
Arrival rate (%) 42.3 (11/26) 73.1 (19/26) 0.048*
Arrival rate (%) (not vis-
ible in fluoroscopy)
28.6 (2/7) 60.0 (9/15) 0.361
Fluoroscopy time (min) 7.8 ± 3.1 8.9 ± 2.8 0.970
Examination time (min) 32.1 ± 10.1 27.1 ± 7.1 0.365
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non-VBN-assisted group [29]. The results of the present 
study, which examined the arrival rate rather than the diag-
nostic yield, were comparable to that of the previous stud-
ies. It should be noted that while VBN assistance provides 
endoscopic-like 3D images for guidance assistance, our 
technique provides fluoroscopic-like projection images. 
Collectively, our results demonstrated that fluoroscopic-
like projection images also provide effective guidance 
assistance during TBB.
The present study had several limitations. First, Ray-
sumTBB only expresses the patient’s status during breath 
holding. When a patient cannot hold his or her breath dur-
ing TBB, differences between the fluoroscopy and Ray-
sumTBB images may be induced by respiration, specifi-
cally near the diaphragm [30]. Second, our sample size 
was small (26 patients in each group), the tumor locations 
were not similar between the control and trial groups, and 
the study design was nonrandomized. Therefore, addi-
tional randomized trials of Ray-sumTBB are required to 
confirm our findings. Moreover, the assistance method 
using Ray-sumTBB should be improved, aiming to shorten 
the examination time and reduce the radiation dose. Nev-
ertheless, following the conclusion of this study, the bron-
choscopists at our hospital have continued to use our tech-
nique employing Ray-sumTBB assistance; thus, we believe 
that this technique may help improve the diagnostic yield 
of TBB for PPLs.
5  Conclusion
In the present study, we proposed and tested the utility of 
Ray-sumTBB image-assisted guidance for locating PPLs dur-
ing TBB examinations under fluoroscopy. Our results dem-
onstrated that this new technique improved the arrival rate 
at PPLs, without increasing the fluoroscopy and examina-
tion times. Ray-sumTBB opened new possibilities for a strong 
navigation tool, and the current study is considered signifi-
cant in establishing the diagnosis of TBB.
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